United Therapeutics (UTHR) Misses Q4 EPS by $2.05, Misses on Revenue
Tweet
Share
E-mail
Get Alerts UTHR Hot Sheet
Price: $496.56 -0.28%
EPS Growth %: -10.1%
Financial Fact:
Net income per basic common share (in dollars per share): 3.75
Today's EPS Names:
SUNB, CULP, KFY, More
EPS Growth %: -10.1%
Financial Fact:
Net income per basic common share (in dollars per share): 3.75
Today's EPS Names:
SUNB, CULP, KFY, More
Join SI Premium – FREE
United Therapeutics (NASDAQ: UTHR) reported Q4 EPS of $2.67, $2.05 worse than the analyst estimate of $4.72. Revenue for the quarter came in at $491.5 million versus the consensus estimate of $519.21 million.
For earnings history and earnings-related data on United Therapeutics (UTHR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Meta stock jumps 5% premarket: Analysts bullish on new Muse AI agent
- Signet Jewelers (SIG) Tops Q2 EPS by 47c, Misses on Revenue; Offers FY27 Guidance
- Chilean Cobalt completes Phase 2 at NeoRe project, gets $1.5M investment
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
